Next Article in Journal
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells
Previous Article in Journal
Predicting Chemotherapy Benefit across Different Races in Early-Stage Breast Cancer Patients Using the Oncotype DX Score
 
 
Article

Article Versions Notes

Cancers 2023, 15(12), 3219; https://doi.org/10.3390/cancers15123219
Action Date Notes Link
article xml file uploaded 16 June 2023 11:43 CEST Original file -
article xml uploaded. 16 June 2023 11:43 CEST Update https://www.mdpi.com/2072-6694/15/12/3219/xml
article pdf uploaded. 16 June 2023 11:44 CEST Version of Record https://www.mdpi.com/2072-6694/15/12/3219/pdf
article supplementary file uploaded. 16 June 2023 11:44 CEST - https://www.mdpi.com/2072-6694/15/12/3219#supplementary
article html file updated 16 June 2023 11:45 CEST Original file -
article html file updated 6 July 2023 20:18 CEST Update https://www.mdpi.com/2072-6694/15/12/3219/html
Back to TopTop